3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Stomach Neoplasms
8
Rectal Neoplasms
8
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasm Metastasis
6
Adenocarcinoma Of Esophagus
6
Adenocarcinoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Pancreatic Neoplasms
4
Esophageal Neoplasms
4
Nasopharyngeal Carcinoma
3
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Biliary Tract Neoplasms
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Solid Tumors
1
Peritoneal Neoplasms
1
Neoplasms
1
HIV Infections
1
HER2-positive Gastric Cancer
1
HER2-positive Breast Cancer
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Bevacizumab
11
durvalumab
9
atezolizumab
9
Specimen Handling
9
tremelimumab
8
lenvatinib
7
Nivolumab
6
Magnetic Resonance Spectroscopy
5
X-Rays
4
Sorafenib
3
Oxaliplatin
3
Ipilimumab
3
Fluorouracil
3
tislelizumab
2
sapanisertib
2
relatlimab
2
cabozantinib
2
Surgical Procedures, Operative
2
Radiation
2
Leucovorin
2
Immunotherapy
2
Immunoglobulin G
2
Doxorubicin
2
Disulfides
2
Carboplatin
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
sofosbuvir-velpatasvir drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Capecitabine
×
30 days
×
Clear all
No trials found.